Search clinical trials for: low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)

Total 387 results

Sinovac Research and Development Co., Ltd.

Completed

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Active, not recruiting

Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)

Coronavirus Disease 2019

China
KK Women's and Children's Hospital
National University Hospital, Singapore; Singapore General Hospital; Changi General... and other collaborators

Unknown

Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

COVID-19

Singapore
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)

Coronavirus

China
University of Ioannina

Recruiting

The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19

Covid19 | End Stage Kidney Disease | Vaccination | Kidney Transplantion

Greece
Oslo University Hospital

Active, not recruiting

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) (SCV-KTx-imm)

Kidney Transplant Infection | SARS-CoV Infection

Norway
Children's Hospital Medical Center, Cincinnati

Active, not recruiting

Antibody Detection of Vaccine-Induced Secretory Effects (ADVISE)

Covid19 | SARS-CoV Infection | Coronavirus | Humoral Acquired Immunodeficiency

United States
University Hospital, Caen

Completed

COVID-19 Vaccines Associated Malaise

Vaccine Adverse Reaction

France
National Vaccine and Serum Institute, China
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Recruiting

A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)

COVID-19

United Arab Emirates
Sky Medical Supplies & Equipments, LLC

Withdrawn

Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test

Covid-19 | SARS-CoV-2 | Coronavirus

United States
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute Ltd

Not yet recruiting

Covid-19 and Influenza Oral Vaccine Study

Influenza, Human | covid19 Infection

Australia
Curevo Inc
Green Cross Corporation; Mogam Biotechnology Research Institute

Active, not recruiting

Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older

Herpes Zoster | Shingles

United States
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI

Covid19 | Overweight

China
NYU Langone Health

Completed

Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA)

Multiple Sclerosis

United States
Gaziosmanpasa Research and Education Hospital

Completed

Does COVİD-19 m-RNA Vaccine Affect Fertility and Over Reserve ?

Vaccine Adverse Reaction | Fertility Disorders | COVID-19 Virus Infection | Ovarian Function Insufficiency

Turkey
TruDiagnostic
Cornell University

Active, not recruiting

Methylation Effects of COV-19 Infection and Vaccinations

Covid19

United States
Pontificia Universidad Catolica de Chile
Sinovac Life Sciences Co., Ltd.

Completed

Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile (CoronaVarCL)

COVID-19 | Vaccines

Chile
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Hunan Provincial Center for Disease Control and Prevention; Guizhou Center... and other collaborators

Recruiting

Safety Study of COVID19 Vaccine on the Market

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity

Coronavirus Disease 2019

China
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease (SIM-PBD)

Covid19 | Adverse Reaction to Vaccine | Diseases, Chronic

China
Osman ERGANIS, PhD, Prof
The Scientific and Technological Research Council of Turkey; MonitorCRO; VETAL...

Terminated

Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults (COVID-19)

Covid19

Turkey
Xijing Hospital

Completed

Epileptic Seizure in Epilepsy Patients After SARS-CoV-2 Vaccination

Vaccine Adverse Reaction | SARS-CoV-2 Acute Respiratory Disease | Epileptic Seizures Related to Drugs

China
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases (SIMPLE)

Liver Diseases | Covid19 | Adverse Reaction to Vaccine

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Recruiting

Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)

Coronavirus Disease 2019

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
First Affiliated Hospital Bengbu Medical College

Completed

Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)

COVID-19

China
Novavax

Completed

A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine (COVID-19)

COVID-19 | Influenza

Australia, New Zealand
Children's Hospital of Chongqing Medical University

Recruiting

Passive Transmission of COVID-19 Antibody From Mother to Infant

Passive Transmission of Maternal and Infant Antibodies

China
PT Bio Farma
Sinovac Life Sciences Co., Ltd.; Faculty of Medicine Universitas Padjadjaran; National Intitute of Health Research and Development, Ministry of Health Republic of Indonesia

Completed

Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine (COVID-19)

SARS-CoV2 Infection

Indonesia
National Taiwan University Hospital
Taoyuan General Hospital, Ministry of Health and Welfare,Taoyuan,Taiwan

Completed

Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination

Healthy Adult Volunteers

Taiwan
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Recruiting

A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)

COVID-19

Uzbekistan
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2

COVID-19

China
Testing Done Simple
Nao Medical Urgent Care

Completed

Assessing Performance of the Testing Done Simple Covid 19 Antigen Test

COVID-19

United States
Ihsan GURSEL, PhD, Prof.
The Scientific and Technological Research Council of Turkey; MonitorCRO; Dr Abdurrahman... and other collaborators

Completed

Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults (COVID-19)

Covid19

Turkey
Guangdong Provincial People's Hospital

Withdrawn

Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor (CoVac-Lung)

Vaccine Adverse Reaction | Lung Cancer | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | Pulmonary Nodule, Solitary | Pulmonary Nodule, Multiple

China
University of Alabama at Birmingham
ViraCor Laboratories

Withdrawn

COVID Vaccine Immunity in Kidney Transplant Recipients

End Stage Renal Disease | Kidney Transplant; Complications
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Zhejiang Provincial Center for Disease Control and Prevention

Completed

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

COVID-19

China
Zhongnan Hospital

Recruiting

The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine

SARS-CoV-2 | Safety | Immunotoxicity

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Zhejiang Provincial Center for Disease Control and Prevention

Recruiting

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization

Prevention of COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization

Prevention of COVID-19

China
IRCCS Sacro Cuore Don Calabria di Negrar

Recruiting

Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies in Vulnerable Groups. (COVaxFragile)

COVID-19

Italy
Novavax

Completed

Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines

COVID-19

United States
Novavax

Not yet recruiting

Phase 3 Strain Change Study for SARS-CoV-2 rS Vaccines (COVID-19)

Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Immuno Cure 3 Limited
The University of Hong Kong

Active, not recruiting

Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

COVID-19

Hong Kong
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Multisite Observational Maternal and Infant Study for COVID-19 (MOMI-Vax)

COVID-19

United States
Fundação de Medicina Tropical Dr. Heitor Vieira...
Butantan Institute

Active, not recruiting

Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity (COVACMANAUS)

Covid19

Brazil
WestVac Biopharma Co., Ltd.

Not yet recruiting

A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination

COVID-19
Noah Merin
Johns Hopkins University

Terminated

Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure

Covid-19 | Sars-CoV2

United States
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Coronavirus Disease 2019

China

Search clinical trials for: low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations